Evidence map›Paper›PMID 34045210›Full record

ArticleeNeuro

Virtual Connectomic Datasets in Alzheimer's Disease and Aging Using Whole-Brain Network Dynamics Modelling.

Lucas Arbabyazd, Kelly Shen, Zheng Wang, Martin Hofmann-Apitius, Petra Ritter, Anthony R McIntosh, Demian Battaglia, Viktor Jirsa

Abstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Excitation-inhibition homeostasis in Alzheimer's disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  5. Creative experiences and brain clocks.Nature communications · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. A Shift Toward Supercritical Brain Dynamics Predicts Alzheimer's Disease Progression.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lucas ArbabyazdInstitut de Neurosciences des Systèmes, Université Aix-Marseille, Institut ational de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1106, Marseille F-13005, France lucas.arbabyazd@gmail.com demian.battaglia@univ-amu.fr viktor.jirsa@univ-amu.fr.
Kelly ShenRotman Research Institute, Baycrest Centre, Toronto, Ontario M6A 2E1, Canada.
Zheng WangRotman Research Institute, Baycrest Centre, Toronto, Ontario M6A 2E1, Canada.
Martin Hofmann-ApitiusFraunhofer Institute for Algorithms and Scientific Computing, Sankt Augustin 53754, Germany.
Petra RitterBrain Simulation Section, Department of Neurology, Charité University Medicine Berlin and Berlin Institute of Health, Berlin 10117, Germany.
Anthony R McIntoshRotman Research Institute, Baycrest Centre, Toronto, Ontario M6A 2E1, Canada.ORCID 0000-0002-1784-5662
Demian BattagliaInstitut de Neurosciences des Systèmes, Université Aix-Marseille, Institut ational de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1106, Marseille F-13005, France lucas.arbabyazd@gmail.com demian.battaglia@univ-amu.fr viktor.jirsa@univ-amu.fr.
Viktor JirsaInstitut de Neurosciences des Systèmes, Université Aix-Marseille, Institut ational de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1106, Marseille F-13005, France lucas.arbabyazd@gmail.com demian.battaglia@univ-amu.fr viktor.jirsa@univ-amu.fr.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
CIHRNIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Large neuroimaging datasets, including information about structural connectivity (SC) and functional connectivity (FC), play an increasingly important role in clinical research, where they guide the design of algorithms for automated stratification, diagnosis or prediction. A major obstacle is, however, the problem of missing features [e.g., lack of concurrent DTI SC and resting-state functional magnetic resonance imaging (rsfMRI) FC measurements for many of the subjects]. We propose here to address the missing connectivity features problem by introducing strategies based on computational whole-brain network modeling. Using two datasets, the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset and a healthy aging dataset, for proof-of-concept, we demonstrate the feasibility of virtual data completion (i.e., inferring "virtual FC" from empirical SC or "virtual SC" from empirical FC), by using self-consistent simulations of linear and nonlinear brain network models. Furthermore, by performing machine learning classification (to separate age classes or control from patient subjects), we show that algorithms trained on virtual connectomes achieve discrimination performance comparable to when trained on actual empirical data; similarly, algorithms trained on virtual connectomes can be used to successfully classify novel empirical connectomes. Completion algorithms can be combined and reiterated to generate realistic surrogate connectivity matrices in arbitrarily large number, opening the way to the generation of virtual connectomic datasets with network connectivity information comparable to the one of the original data.

Indexed as

Alzheimer DiseaseConnectomeBrainHumansMagnetic Resonance ImagingNeuroimagingagingAlzheimer’s diseasesconnectomedataset completionfMRIwhole-brain modelling

Identifiers

PMID34045210
PMCPMC8260273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.